Treatment of Kocuria kristinae Bacteremia
Kocuria kristinae isolated from blood culture should be treated as a true pathogen when found in immunocompromised patients, those with indwelling catheters, or when isolated from multiple blood culture sets, with vancomycin as the preferred initial therapy. 1, 2
Initial Assessment: Contamination vs. True Infection
Determine clinical significance before initiating treatment:
- True bacteremia is likely when K. kristinae grows in multiple blood culture sets from separate venipuncture sites, or when isolated from both blood and catheter tip simultaneously 3, 2
- Contamination is more likely when only a single blood culture set is positive, particularly if the patient has other recognized infections and lacks clinical signs of sepsis 2
- High-risk patients include premature infants, immunocompromised hosts (malignancy, chemotherapy), and those with long-term central venous catheters 4, 2, 5
Recommended Antibiotic Therapy
First-line treatment:
- Vancomycin is the most effective agent with highest susceptibility rates and should be used as initial parenteral therapy 1
- Combination therapy with vancomycin plus another susceptible antibiotic is recommended for initial treatment 1
- Alternative agents with high susceptibility include linezolid, rifampicin, teicoplanin, tigecycline, cefotaxime, ampicillin/sulbactam, minocycline, and meropenem 1
Treatment duration:
- 14-16 days of parenteral therapy has been successful in documented cases 4
- Adjust based on clinical response and source control measures 4
Source Control Considerations
Catheter management is critical:
- Remove or replace central venous catheters when K. kristinae is isolated from catheter-drawn blood cultures, especially if catheter-related bloodstream infection is suspected 4, 2
- Ethanol lock therapy (5 days) can be considered as adjunctive treatment for catheter salvage in select cases 4
- Culture the catheter tip if removed to confirm catheter-related infection 2
Important Caveats
Resistance patterns are concerning:
- Universal resistance to penicillin and oxacillin has been documented in recent isolates 5
- Do not use penicillin or oxacillin as empiric therapy 5
- Obtain susceptibility testing for all isolates to guide definitive therapy, as resistance patterns are evolving 5
Clinical pitfalls to avoid:
- Do not dismiss as contaminant in immunocompromised patients or those with indwelling catheters, even if only one culture is positive 2, 5
- Repeat blood cultures from separate peripheral venipuncture sites (at least 2 sets of 20-30 mL each) if contamination is suspected but clinical sepsis is present 6, 3
- Misidentification risk: K. kristinae resembles coagulase-negative staphylococci and requires proper identification systems (VITEK 2 or equivalent) 5, 7
Monitoring and Follow-up
Treatment is almost universally effective: